Chemoinformaics analysis of 1-Methyl-1,3-cyclohexadiene
| Molecular Weight | 94.157 | nRot | 0 |
| Heavy Atom Molecular Weight | 84.077 | nRig | 6 |
| Exact Molecular Weight | 94.0782 | nRing | 1 |
| Solubility: LogS | -2.007 | nHRing | 0 |
| Solubility: LogP | 2.038 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 18.3579 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.432 |
| Synth | 2.916 |
| Natural Product Likeliness | 3.143 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.013 |
| HIA | 0.004 |
| CACO-2 | -4.386 |
| MDCK | 0.0000301 |
| BBB | 0.922 |
| PPB | 0.775388 |
| VDSS | 2.626 |
| FU | 0.290041 |
| CYP1A2-inh | 0.395 |
| CYP1A2-sub | 0.863 |
| CYP2c19-inh | 0.115 |
| CYP2c19-sub | 0.909 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.814 |
| CYP2d6-inh | 0.125 |
| CYP2d6-sub | 0.913 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.325 |
| CL | 1.775 |
| T12 | 0.744 |
| hERG | 0.035 |
| Ames | 0.146 |
| ROA | 0.539 |
| SkinSen | 0.961 |
| Carcinogencity | 0.793 |
| EI | 0.99 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.92963 |